SCHEMBL24743148

SCHEMBL24743148

C[PH](C)(O)c1c(N)ccc2nc(Cl)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.34
NR4A2 P43354 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CYP2C19 P33261 2/20 0.32
HIF1A Q16665 2/20 0.32
CYP3A4 P08684 1/20 0.32
GNG2 P59768 2/20 0.31
GNB1 P62873 2/20 0.31
BLM P54132 2/20 0.31
MPO P05164 1/20 0.31
GMNN O75496 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
PKM P14618 1/20 0.31
TSHR P16473 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MTOR P42345 1/20 0.31
PMP22 Q01453 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25083068 0.75 IMPDH2 (0.42) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL22951342 0.75 NR4A2 (0.40) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL24742611 0.73 MAPT (0.56) IDO1NR4A2KDM4EHIF1ACYP3A4
SCHEMBL22951353 0.72 IDO1 (0.38) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL24207461 0.71 CYP2C19 (0.39) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL24207416 0.71 IDO1 (0.35) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL22950952 0.69 IDO1 (0.33) IDO1NR4A2KDM4ECYP2C19HIF1A
SCHEMBL3844688 0.68 KDM4E (0.44) IDO1KDM4ECYP2C19HIF1ACYP3A4
SCHEMBL20915738 0.68 IDO1 (0.35) IDO1NR4A2KDM4EHIF1ALMNA
SCHEMBL116741 0.67 ALDH1A1 (0.50) IDO1NR4A2KDM4ECYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105207-A1 QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2022-12-21 EP disclosed